Drug Profile
Research programme: somatropin oral - Access Pharmaceuticals
Alternative Names: cobalamin-coated hGH-containing nanoparticles; CobOral™ hGH; CobOral™ somatropinLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Access Pharmaceuticals
- Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins
- Mechanism of Action Somatotropin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Growth disorders